UCB is adding a big piece to its immunology pipeline with a multi-billion dollar deal to buy Candid Therapeutics, a clinical-stage biotech company developing therapies in a promising but competitive ...

UCB UCB-0.35%decrease; down pointing triangle said it agreed to buy Candid Therapeutics for up to $2.2 billion, in a deal that seeks to bolster the Belgian pharmaceutical company’s pipeline of ...

After a recent streak of buyouts by some of Big Pharma's serial acquirers, Belgium's UCB is getting in on the action with a Friday acquisition potentially worth more than $1 billion. Building on its ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first plant in the U.S. for the Belgium-based company and will produce ...

Abstract: Mobile Edge Computing (MEC) is an emerging network architecture designed to enhance Quality of Service (QoS) by bringing computational resources and storage closer to end users. In MEC ...

The energy that powers cells of the human body comes from tiny cellular components called mitochondria. Just as a draining battery makes it difficult to operate an electronic device, mitochondrial ...

`oops, just found the 'maxscore' didn't update, although the code has passed all the tests. update, modified score and maxScore funtions update, misunderstood the game score rule, actually the first ...

Efficient Learning Algorithms for the Best Capped Base-Stock Policy in Lost Sales Inventory Systems Periodic review, lost sales inventory systems with lead times are notoriously challenging to ...

UCB of Belgium and CDMO Samsung Biologics of South Korea have expanded their seven-year partnership with a new drug substance manufacturing deal worth 382 billion Korean won ($288 million). Among the ...

In four new studies, researchers found complicated results from experiments on Facebook’s and Instagram’s algorithms, suggesting there was no silver bullet to fixing the platforms. By Mike Isaac and ...